Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000522896 | SCV000619238 | uncertain significance | not specified | 2017-07-26 | criteria provided, single submitter | clinical testing | The R2524C variant in the OTOG gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. Reliable data is not available in large population cohorts to assess the frequency of this variant in publicly available databases; however, the R2524C variant is observed in 73/76,088 (0.1%) alleles from individuals undergoing testing at GeneDx, and no individuals are reported to be homozygous. The R2524C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Arginine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret R2524C as a variant of uncertain significance. |
Labcorp Genetics |
RCV002060271 | SCV002336414 | benign | not provided | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962448 | SCV004782947 | benign | OTOG-related disorder | 2024-09-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |